Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Altimmune Inc (3G0)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.261 +0.023    +0.32%
02:16:38 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US02155H2004 
S/N:  A2N5Z6
  • Volume: 1
  • Bid/Ask: 7.261 / 7.519
  • Day's Range: 7.261 - 7.289
Altimmune 7.261 +0.023 +0.32%

NASDAQ:3G0 Financials

 
A brief overview of the NASDAQ:ALT financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of PharmAthene over time.

Altimmune, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 0.005 million compared to USD 0.021 million a year ago. Net loss was USD 24.39 million compared to USD 20.07 million a year ago. Basic loss per share from continuing operations was USD 0.34 compared to USD 0.4 a year ago. Diluted loss per share from continuing operations was USD 0.34 compared to USD 0.4 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

3G0 Income Statement

Gross margin TTM -16,982.2%
Operating margin TTM -21,596.34%
Net Profit margin TTM -22,626.1%
Return on Investment TTM -44.5%
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 0.005 0.037 0.362 0.006
Gross Profit -21.48 -16.87 -18.03 -13.25
Operating Income -26.79 -21.2 -22.54 -18.01
Net Income -24.39 -31.64 -20.67 -16.06

3G0 Balance Sheet

Quick Ratio MRQ 16.09
Current Ratio MRQ 16.55
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 0.32%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 188.36 210.64 166.57 183.32
Total Liabilities 15.42 16.54 16.18 15.6
Total Equity 172.94 194.1 150.4 167.71

3G0 Cash Flow Statement

Cash Flow/Share TTM -1.03
Revenue/Share TTM 0.01
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -16.53 -20.49 -19.38
Cash From Investing Activities -7.96 4.4 3.99
Cash From Financing Activities 72.75 0.588 13.06
Net Change in Cash 48.26 -15.5 -2.33
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALT Comments

Write your thoughts about Altimmune Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jack Belforte
Jack Belforte Apr 02, 2024 7:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Some analysts are missing the bigger picture. ALT may surprise a few skeptics.
Seen see
ThurstonHowell Apr 02, 2024 7:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Let's hope Garg can sell.or partner up.
Jack Belforte
Jack Belforte Apr 01, 2024 8:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Accumulation showing ALT is back on the map.
Jack Belforte
Jack Belforte Mar 29, 2024 9:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Major reversal on ALT due to Wednesday update. Positive investor reaction.
Mason Cutlip
Mason Cutlip Mar 05, 2024 11:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
last Chance to get in here.
Jack Belforte
Jack Belforte Feb 22, 2024 8:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sadly ALT is losing investors.
Mason Cutlip
Mason Cutlip Feb 22, 2024 8:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tutes increased their holdings LOL unfortunately Margin Calls and forced liquidation is about to become a reality for shorts
Jack Belforte
Jack Belforte Feb 14, 2024 9:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ALT losing its grip due to viability concerns as well as others.
Jack Belforte
Jack Belforte Feb 13, 2024 6:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ALT may have stalled due to concerns of viability and strong competition. $8-$10
Jack Belforte
Jack Belforte Feb 08, 2024 6:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ALT could rise to the $15 levels
Douglas Langston
Douglas Langston Jan 19, 2024 12:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why are we tanking today?
Charles Resheske
Charles Resheske Dec 07, 2023 8:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
upgrade to 16
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email